Research article · 31 Oct 2014
Review articlePublished 2014
AMPK Activators as a Drug for Diabetes, Cancer and Cardiovascular Disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The cellular mechanisms of AMP-Activated Protein Kinase (AMPK) activators in the treatment and prevention of diabetes, cancer, and cardiovascular disease (Graphical abstract).
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 27 Oct 2023
Mechanism of Puerarin Regulating AMPK/mTOR Activated Autophagy Signal Pathway in the Treatment of Diabetic Nephropathy
Commentary · 2013
At the Center of the Metabolism and Cancer Web: AMP-Activated Protein Kinase (AMPK)
Research article · 18 May 2016
Age- and sex-related prevalence and drug utilization pattern in the management of type 2 diabetes mellitus and its comorbidity with cardiovascular diseases: A comparative study
Review article · 2012
Pharmacogenomics- Personalized Treatment of Cancer, Diabetes and Cardiovascular Diseases
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mark Goodman”
- BylineArticles whose byline prints “Zhenling Liu”
- BylineArticles whose byline prints “Ping Zhu”
- BylineArticles whose byline prints “Ji Li”

